These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 14046626)

  • 1. ENZYME ALTERABLE ALKYLATING AGENTS. V. DESIGN OF SULFUR MUSTARDS WITH VARYING DEGREES OF HYDROLYTIC STABILITY IN A SEARCH FOR SHORT BIOLOGICAL HALF-LIFE AGENTS.
    WILLIAMSON CE; MILLER JI; SASS S; CASANOVA J; KRAMER SP; SELIGMAN AM; WITTEN B
    J Natl Cancer Inst; 1963 Aug; 31():273-96. PubMed ID: 14046626
    [No Abstract]   [Full Text] [Related]  

  • 2. Enzyme-alterable alkylating agents. I. Synthesis, chemical properties, and toxicities of sulfur mustards containing enzyme-susceptible amide bonds.
    WITTEN B
    Cancer; 1962; 15():1041-55. PubMed ID: 14007768
    [No Abstract]   [Full Text] [Related]  

  • 3. ENZYME-ALTERABLE ALKYLATING AGENTS. VII. THE DESIGN OF SHORT-LIVED MUSTARDS.
    SASS S; WILLIAMSON CE; KRAMER SP; GOODMAN LE; ULFOHN A; SELIGMAN AM; WITTEN B
    J Med Chem; 1965 Jan; 8():14-7. PubMed ID: 14287258
    [No Abstract]   [Full Text] [Related]  

  • 4. New short half-life alkylating agents for intra-arterial regional chemotherapy.
    WITTEN B; WILLIAMSON CE; MILLER JI; SASS S; KRAMER SP; GOODMAN LE; ULFOHN A; SELIGMAN AM
    Cancer Chemother Rep; 1962 Feb; 16():515-6. PubMed ID: 14007767
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulfur and nitrogen mustards induce characteristic poly(ADP-ribosyl)ation responses in HaCaT keratinocytes with distinctive cellular consequences.
    Mangerich A; Debiak M; Birtel M; Ponath V; Balszuweit F; Lex K; Martello R; Burckhardt-Boer W; Strobelt R; Siegert M; Thiermann H; Steinritz D; Schmidt A; Bürkle A
    Toxicol Lett; 2016 Feb; 244():56-71. PubMed ID: 26383629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-alterable alkylating agents. III. Synthesis, chemical properties, and toxicities of mustards containing enzyme-susceptible ester bonds.
    WITTEN B; SASS S; MILLER JI; WILLIAMSON CE; GUERRERO HG; KRAMER SP; SOLOMON RD; GOODMAN LE; SELIGMAN AM
    Cancer; 1962; 15():1062-72. PubMed ID: 14007766
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzyme alterable alkylating agents: a new approach to regional chemotherapy by intra-arterial infusion of new short-lived alkylating agents.
    SELIGMAN AM
    Ann Surg; 1962 Sep; 156(3):429-41. PubMed ID: 13910425
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative investigation of the chemotherapeutic action of N-oxide-mustard gas and other alkylating compounds in rat tumors].
    DANNEBERG P; DRUCKREY H; KAISER K; LO HW; MECKE R; NIEPER HA; SCHMAHL D
    Arzneimittelforschung; 1956 Sep; 6(9):539-50. PubMed ID: 13373668
    [No Abstract]   [Full Text] [Related]  

  • 9. Enzyme-alterable alkylating agents. IX. The enzymatic transformation of some nitrogen mustards in the presence of carbon dioxide: implications in respiration.
    Williamson CE; Kirby JG; Miller JI; Sass S; Kramer SP; Seligman AM; Witten B
    Cancer Res; 1966 Feb; 26(2):323-30. PubMed ID: 5903181
    [No Abstract]   [Full Text] [Related]  

  • 10. Survey of sulfur mustards.
    HUNTRESS WT; GOODRIDGE TH; BRATZEL RP
    Cancer Chemother Rep; 1963 Jan; 26():323-39. PubMed ID: 13955800
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of sulfur mustard and nitrogen mustard on corneal collagen degradation induced by the enzyme collagenase.
    Naderi M; Jadidi K; Falahati F; Alavi SA
    Cutan Ocul Toxicol; 2010 Dec; 29(4):234-40. PubMed ID: 20545579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative toxicity of mono- and bifunctional alkylating homologues of sulphur mustard in human skin keratinocytes.
    Sawyer TW; McNeely K; Louis K; Lecavalier P; Song Y; Villanueva M; Clewley R
    Toxicology; 2017 May; 382():36-46. PubMed ID: 28285101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkylating agents and DNA polymerases.
    Bignold LP
    Anticancer Res; 2006; 26(2B):1327-36. PubMed ID: 16619541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantum molecular modeling of the interaction between guanine and alkylating agents--1--sulfur mustard.
    Broch H; Hamza A; Vasilescu D
    J Biomol Struct Dyn; 1996 Jun; 13(6):903-14. PubMed ID: 8832373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carcinogenesis due to mustard gas exposure in man, important sign for therapy with alkylating agents].
    Weiss A; Weiss B
    Dtsch Med Wochenschr; 1975 Apr; 100(17):919-23. PubMed ID: 1122860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of DNA sequence and minor groove selective alkylating agents.
    Lee M; Rhodes AL; Wyatt MD; Forrow S; Hartley JA
    Anticancer Drug Des; 1993 Jun; 8(3):173-92. PubMed ID: 8517912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives.
    Singh RK; Kumar S; Prasad DN; Bhardwaj TR
    Eur J Med Chem; 2018 May; 151():401-433. PubMed ID: 29649739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second.
    Goodman LE; Ulfohn A; Kramer SP; Cendana EH; Flores AB; Bakal D; Abrams SJ; Hirschfeld RL; Calle S; Williamson CE; Sass S; Witten B; Seligman AM
    Ann Surg; 1965 Oct; 162(4):663-89. PubMed ID: 5319397
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacterial mutagenicity studies of DNA-intercalating aniline mustards: an insight into the mode of action of a novel class of anti-tumour drugs.
    Ferguson LR; Gourdie TA; Valu KK; Denny WA
    Anticancer Drug Des; 1989 Oct; 4(3):209-19. PubMed ID: 2679621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA repair mechanisms in response to genotoxicity of warfare agent sulfur mustard.
    Panahi Y; Fattahi A; Nejabati HR; Abroon S; Latifi Z; Akbarzadeh A; Ghasemnejad T
    Environ Toxicol Pharmacol; 2018 Mar; 58():230-236. PubMed ID: 29428683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.